Product
Dolutegravir + Tenofovir DF + Lamivudine or Emtricitabine
1 clinical trial
1 indication
Indication
HIV-1 infectionClinical trial
Phase III, Open-label, Randomized, Multicenter Trial EvaLuating the Non-inferiority of DORAvirine Versus DOlutegravir Based Antiretroviral Regimens in Treatment-naïve People Living With HIV-1 InfectionStatus: Not yet recruiting, Estimated PCD: 2026-04-01